Fundz

Biogen completes acquisition of RayThera Inc.

PUBLIC · TLRYAug 06, 2026

Acquiring Company

Tilray Medical

Acquired Company

RayThera

SeattleSan DiegoOtherInformation TechnologyBiotechnologyAgriculture and FarmingSoftwareHealth CareEducationMedicalAnalyticsCannabisBiotechnologyPharmaceutical

Description

Biogen Inc. announced the completion of its acquisition of RayThera Inc., enhancing its immunology portfolio. The acquisition includes multiple assets aimed at treating immune-mediated conditions. The lead program has entered Phase 1 development in July 2026, highlighting Biogen's commitment to innovation in this area. This acquisition reflects Biogen's strategy to strengthen and diversify its research pipeline.

Company Information

Company

Tilray Medical

Location

E El Segundo Blvd

Seattle, Washington, United States

About

Tilray Brands, Inc. is a leading global lifestyle and consumer packaged goods company with a focus on cannabis, beverage, wellness, and entertainment. The company aims to elevate lives through moments of connection, offering a house of brands and innovative products. Tilray operates in Canada, the United States, Europe, Australia, and Latin America, supporting over 40 brands across more than 20 countries.

Fundz sees it the moment Tilray Medical makes an acquisition, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

Chris
Likely contact at this company
••••••••@••••••••

See Chris's verified email →

Adam
Senior decision-maker at this company
••••••••@••••••••

See Adam's verified email →

Frank
Senior decision-maker at this company
••••••••@••••••••

See Frank's verified email →

Create an account to reveal verified emails
Predictive Intelligence
Strategic

ML-powered predictions for Tilray Medical's next move

Learn about Strategic plan

Frequently asked

Who acquired RayThera?

RayThera was acquired by Tilray Medical, based in Seattle. The deal was reported on August 6, 2026. Tilray Brands, Inc. is a leading global lifestyle and consumer packaged goods company with a focus on cannabis, beverage, wellness, and entertainment. Tilray Medical is publicly traded (TLRY) and operates in Other.

When did Tilray Medical acquire RayThera?

Tilray Medical's acquisition of RayThera was reported on August 6, 2026. Biogen Inc. announced the completion of its acquisition of RayThera Inc., enhancing its immunology portfolio. The acquisition includes multiple assets aimed at treating immune-mediated conditions. Fundz records the date the transaction was first publicly reported, sourced from filings and company announcements.

What does RayThera do?

RayThera, Inc. is a small molecule drug discovery company focused on building an immunology pipeline. The company is led by a team of highly skilled drug hunters with extensive experience in the biotech and pharma industries. It is privately held, operating in Biotechnology, and is based in San Diego.

This company was part of an acquisition. Fundz tracks who bought whom, and who to call on both sides.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include FundzWatch™ for automated website change detection, Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.